Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective studyKazuhiro Takahashi, Takahiro Kimura, Akira Furuta et al.|Japanese Journal of Clinical Oncology|2023Cited by 13
The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiationSoshi Kadena, Takahiro Kimura, Fumihiko Urabe et al.|International Journal of Clinical Oncology|2023Cited by 7
Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancerWataru Fukuokaya, Shin Egawa, Takahiro Kimura et al.|International Journal of Clinical Oncology|2020Cited by 5
Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancerKeiichiro Miyajima, Takahiro Kimura, Hirotaka Suzuki et al.|International Journal of Clinical Oncology|2023Cited by 4
Clinical Significance of Intraductal Carcinoma of the Prostate After High-Dose Brachytherapy With External Beam Radiation Therapy: A Single Institution Series and an Updated Meta-AnalysisKeiichiro Miyajima, Takahiro Kimura, Shun Sato et al.|Clinical Genitourinary Cancer|2023Cited by 3